Loading...
•
Dec 31, 2021
Maravai Q4 2021 Earnings Report
Reported financial results for the fourth quarter and the full year ended December 31, 2021.
Key Takeaways
Maravai LifeSciences reported a strong fourth quarter with revenue of $228.4 million, a 132% increase over the prior year, and net income of $127.1 million, representing a 778% growth. The company's full-year revenue reached $799.2 million, up 181% from the previous year.
Fourth quarter 2021 revenue increased 132% over the prior year.
Net income for the fourth quarter grew 778% over the prior year.
Full year 2021 revenue increased 181% over the prior year.
Increased 2022 revenue guidance range to $920.0 million to $960.0 million.
Revenue by Segment
Forward Guidance
Total revenue for 2022 is expected to be in the range of $920.0 million to $960.0 million, reflecting overall growth of 15% to 20%. Adjusted EBITDA (non-GAAP) is expected to be in the range of $630.0 million to $670.0 million. Adjusted fully diluted EPS (non-GAAP) is expected to be in the range of $1.70 - $1.84 per share. 2022 interest expense is expected to be in the range of $22.0 million to $25.0 million, 2022 depreciation and amortization is expected to be in the range of $22.0 million to $25.0 million, and 2022 equity-based compensation is expected to be in the range of $15.0 million to $20.0 million.
Positive Outlook
- Total revenue for 2022 is expected to be in the range of $920.0 million to $960.0 million
- Overall revenue growth of 15% to 20% is expected.
- Adjusted EBITDA (non-GAAP) is expected to be in the range of $630.0 million to $670.0 million.
- Adjusted fully diluted EPS (non-GAAP) is expected to be in the range of $1.70 - $1.84 per share.
- 2022 interest expense is expected to be in the range of $22.0 million to $25.0 million
Challenges Ahead
- Guidance does not include the financial impact of potential new acquisitions.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...